From Portfolios
Making a comeback: Nusantics’ CEO on a playbook for resilience and agility
When Nusantics launched its first PCR test kits for COVID-19 in 2020, it seemed destined to be a biotech success story. However, behind the scenes, the company was waging a battle against forces threatening its very existence. Revata Utama, the firm’s CEO and co-founder, recently…
